EGFR and pancreatic neoplasm: Additionally, it was recently shown that ROS-induced PKD1-mediated NF-κB activity results in the upregulation of epidermal growth factor receptor (EGFR) signaling components (EGFR and its ligand TGFα) in pancreatic cancer downstream of oncogenic Ras [87].